The DOI matches its Crossref record; 254 of the 254 references it cites were found in a registry or an index.
Fluorine in Pharmaceutical Industry: Fluorine-Containing Drugs Introduced to the Market in the Last Decade (2001–2011)
Abstract
ADVERTISEMENT RETURN TO ISSUEPREVReviewNEXTFluorine in Pharmaceutical Industry: Fluorine-Containing Drugs Introduced to the Market in the Last Decade (2001–2011)Jiang Wang†, María Sánchez-Roselló‡§, José Luis Aceña∥, Carlos del Pozo‡, Alexander E. Sorochinsky∥⊥#, Santos Fustero*‡§, Vadim A. Soloshonok*∥⊥, and Hong Liu*†View Author Information† Key Laboratory of Receptor Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 555 Zu Chong Zhi Road, Shanghai 201203, China‡ Department of Organic Chemistry, Faculty of Pharmacy, University of Valencia, Av. Vicente Andrés Estellés, 46100 Burjassot, Valencia, Spain§ Laboratorio de Moléculas Orgánicas, Centro de Investigación Príncipe Felipe, C/ Eduardo Primo Yúfera 3, 46012 Valencia, Spain∥ Department of Organic Chemistry I, Faculty of Chemistry, University of the Basque Country UPV/EHU, Paseo Manuel Lardizábal 3, 20018 San Sebastian, Spain⊥ IKERBASQUE, Basque Foundation for Science, Alameda Urquijo, 36-5 Plaza Bizkaia, 48011 Bilbao, Spain# Institute of Bioorganic Chemistry and Petrochemistry, National Academy of Sciences of Ukraine, Murmanska Street 1, 02660 Kyiv-94, Ukraine*E-mail: [email protected]*E-mail: [email protected]*E-mail: [email protected]Cite this: Chem. Rev. 2014, 114, 4, 2432–2506Publication Date (Web):December 3, 2013Publication History Received27 May 2013Published online3 December 2013Published inissue 26 February 2014https://pubs.acs.org/doi/10.1021/cr4002879https://doi.org/10.1021/cr4002879review-articleACS PublicationsCopyright © 2013 American Chemical SocietyRequest reuse permissionsArticle Views48704Altmetric-Citations3850LEARN ABOUT THESE METRICSArticle Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.Citations are the number of other articles citing this article, calculated by Crossref and updated daily. Find more information about Crossref citation counts.The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on the Altmetric Attention Score and how the score is calculated. Share Add toView InAdd Full Text with ReferenceAdd Description ExportRISCitationCitation and abstractCitation and referencesMore Options Share onFacebookTwitterWechatLinked InRedditEmail Other access optionsGet e-Alertsclose SUBJECTS:Anions,Fluorine,Organic compounds,Pharmaceuticals,Reaction products Get e-Alerts
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–254 of 254
Pharmacotherapy of the third-generation AEDs: lacosamide, retigabine and eslicarbazepine acetate
Patsalos, P. N., & Berry, D. J. (2012) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2012.667803 · Cited by 44
Role of Prasugrel, a Novel P2Y12 Receptor Antagonist, in the Management of Acute Coronary Syndromes
Baker, W. L., & White, C. M. (2009) · American Journal of Cardiovascular Drugs · doi:10.2165/1131209-000000000-00000 · Cited by 43
Earl, J., & Kirkpatrick, P. N. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1015 · Cited by 41
Lactone Pathway to Statins Utilizing the Wittig Reaction. The Synthesis of Rosuvastatin
Časar, Z., Steinbücher, M., & Košmrlj, J. (2010) · The Journal of Organic Chemistry · doi:10.1021/jo101050z · Cited by 40
Aceña, J. L., Sorochinsky, A. E., Katagiri, T., & Soloshonok, V. A. (2012) · Chemical Communications · doi:10.1039/c2cc37491a · Cited by 39
Self-citationMedicinal Chemistry of Selective Neurokinin-1 Antagonists
Humphrey, J. M. (2003) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026033451925 · Cited by 39
Posaconazole: A Next-Generation Triazole Antifungal
Farowski, F., Vehreschild, J. J., & Cornely, O. A. (2007) · Future Microbiology · doi:10.2217/17460913.2.3.231 · Cited by 37
Ogawa, S., Nishimine, T., Tokunaga, E., Nakamura, S., & Shibata, N. (2009) · Journal of Fluorine Chemistry · doi:10.1016/j.jfluchem.2009.12.002 · Cited by 37
Fabio, R. D., Alvaro, G. S., Griffante, C., Pizzi, D. A., Donati, D., Mattioli, M., Cimarosti, Z., Guercio, G., Marchioro, C., Provera, S., et al. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm1013264 · Cited by 36
Citrome, L. (2012) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2012.693160 · Cited by 35
McKeage, K., Plosker, G. L., & Siddiqui, M. A. A. (2006) · Drugs · doi:10.2165/00003495-200666060-00015 · Cited by 35
Verstovšek, S., Giles, F. J., Quintás‐Cardama, A., Manshouri, T., Huynh, L., Manley, P. W., Cortes, J. E., Tefferi, A., & Kantarjian, H. M. (2006) · Leukemia Research · doi:10.1016/j.leukres.2006.03.012 · Cited by 34
The MET axis as a therapeutic target
Sattler, M., & Salgia, R. (2009) · Update on Cancer Therapeutics · doi:10.1016/j.uct.2009.01.001 · Cited by 34
Deeks, E. D. (2011) · Drugs · doi:10.2165/11206850-000000000-00000 · Cited by 34
Huber, K., Hamad, B., & Kirkpatrick, P. N. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3418 · Cited by 34
Soloshonok, V. A., Kacharov, A. D., Avilov, D. V., & Hayashi, T. (1996) · Tetrahedron Letters · doi:10.1016/0040-4039(96)01746-7 · Cited by 33
Self-citationThe position not the presence of the halogen in corticosteroids influences potency and side effects.
Bikowski, J., Pillai, R., & Shroot, B. (2006) · PubMed · Cited by 32
Henschke, J. P., Liu, Y., Huang, X., Chen, Y., Meng, D., Xia, L., Wei, X., Xie, A., Li, D., Huang, Q., et al. (2012) · Organic Process Research & Development · doi:10.1021/op300188x · Cited by 32
Self-citationBrocco, M., Dekeyne, A., la Cour, C. M., Touzard, M., Girardon, S., Veiga, S., Nanteuil, G. D., A, T. R. D. J., Olivier, B., & Millan, M. J. (2008) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2008.06.002 · Cited by 31
Anaplastic lymphoma kinase as a therapeutic target
Kruczynski, A., Delsol, G., Laurent, C., Brousset, P., & Lamant, L. (2012) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2012.719498 · Cited by 30
Szczeciński, P., Gryff‐Keller, A., & Molchanov, S. (2006) · The Journal of Organic Chemistry · doi:10.1021/jo060583g · Cited by 30
Konosu, T., TAJIMA, Y., Takeda, N., et al. (1990) · Chemical and Pharmaceutical Bulletin · doi:10.1248/cpb.38.2476 · Cited by 30
Synthesis of fluorine-containing compounds under operationally convenient conditions
Soloshonok, V. A., & Berbasov, D. O. (2004) · Journal of Fluorine Chemistry · doi:10.1016/j.jfluchem.2004.09.010 · Cited by 29
Self-citationKauffman, C. A., Malani, A. N., Easley, C., & Kirkpatrick, P. J. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2270 · Cited by 29
Bennett, F., Saksena, A. K., Lovey, R. G., Liu, Y., Patel, N. M., Pinto, P. A., Pike, R. E., Jao, E., GIRIJAVALLABHAN, V. M., Ganguly, A. K., et al. (2005) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2005.09.031 · Cited by 28
Hepperle, M. E., Eckert, J., & Gala, D. (1999) · Tetrahedron Letters · doi:10.1016/s0040-4039(99)01103-x · Cited by 27
Pye, P. J., Zhong, Y., Jones, G. O., Reamer, R. A., Houk, K. N., & Askin, D. (2008) · Angewandte Chemie International Edition · doi:10.1002/anie.200703681 · Cited by 26
Rosuvastatin for the Treatment of Hypercholesterolemia
Culhane, N. S., Lettieri, S. L., & Skae, J. R. (2005) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.2005.25.7.990 · Cited by 25
Carletti, R., Corsi, M., Melotto, S., & Caberlotto, L. (2005) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2005.04002.x · Cited by 25
Concise and highly efficient approach to three key pyrimidine precursors for rosuvastatin synthesis
Šterk, D., Časar, Z., Jukič, M., & Košmrlj, J. (2012) · Tetrahedron · doi:10.1016/j.tet.2012.01.013 · Cited by 25
A Water-Based Mechanism of Specificity and Resistance for Lapatinib with ErbB Family Kinases
Huang, Y., & Rizzo, R. C. (2012) · Biochemistry · doi:10.1021/bi2016553 · Cited by 24
Suzuki, M., Yanagawa, Y., Iwasaki, H., Kanda, H., Yanagihara, K., Matsumoto, H., Ohara, Y., Yazaki, Y., & Sakoda, R. (1999) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(99)00519-3 · Cited by 23
Rosuvastatin is cost-effective compared with atorvastatin in reaching cholesterol goals
Hirsch, M., O’Donnell, J. C., & OLSSON, A. G. (2005) · International Journal of Cardiology · doi:10.1016/j.ijcard.2004.09.015 · Cited by 23
Duggan, S. T., & Keating, G. M. (2009) · Drugs · doi:10.2165/10484190-000000000-00000 · Cited by 23
The use of newer antiepileptic drugs in patients with renal failure
Diaz, A., Deliz-Tirado, B., & Benbadis, S. R. (2011) · Expert Review of Neurotherapeutics · doi:10.1586/ern.11.181 · Cited by 23
Highly stereoselective hydrogenations—As key‐steps in the total synthesis of statins
Andrushko, N. V., Andrushko, V., Tararov, V. I., Korostylev, A., König, G., & Börner, A. (2009) · Chirality · doi:10.1002/chir.20782 · Cited by 22
Besifloxacin, a new ophthalmic fluoroquinolone for the treatment of bacterial conjunctivitis
Bertino, J., & Zhang, J. (2009) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656560903213413 · Cited by 22
Some Metabolic Aspects of Fluoroacetate Especially Related to Fluorocitrate
Peters, R. A. (1972) · Novartis Foundation symposium · doi:10.1002/9780470719855.ch4 · Cited by 21
Hegde, S. G., & Schmidt, M. A. (2008) · Annual reports in medicinal chemistry · doi:10.1016/s0065-7743(08)00025-0 · Cited by 21
Synthesis of the Chiral Side Chain of Statins – Lactone versus Lactol Pathway
Tararov, V. I., Andrushko, N. V., Andrushko, V., König, G., Spannenberg, A., & Börner, A. (2006) · European Journal of Organic Chemistry · doi:10.1002/ejoc.200600849 · Cited by 19
The emerging role of ALK inhibitors in the treatment of advanced non-small cell lung cancer
Galetta, D., Rossi, A., Pisconti, S., & Colucci, G. (2012) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2011.642372 · Cited by 18
Theoretical investigations into the enantiomeric and racemic forms of α-(trifluoromethyl)lactic acid
Tonner, R., Soloshonok, V. A., & Schwerdtfeger, P. (2010) · Physical Chemistry Chemical Physics · doi:10.1039/c0cp01155j · Cited by 18
Self-citationCarter, N. J., & Scott, L. (2009) · Drugs · doi:10.2165/00003495-200969090-00007 · Cited by 17
Fosaprepitant for the prevention of chemotherapy-induced nausea and vomiting
Ruhlmann, C. H., & Herrstedt, J. (2012) · Expert Review of Anticancer Therapy · doi:10.1586/era.11.199 · Cited by 16
Ezogabine: A New Angle on Potassium Gates
Faught, E. (2011) · Epiliepsy currents/Epilepsy currents · doi:10.5698/1535-7511-11.3.75 · Cited by 14
Gefitinib for non-small-cell lung cancer treatment
D’Incecco, A., & Cappuzzo, F. (2011) · Expert Opinion on Drug Safety · doi:10.1517/14740338.2011.617738 · Cited by 13
Troiani, V., Cluzeau, J., & Časar, Z. (2011) · Organic Process Research & Development · doi:10.1021/op100341m · Cited by 13
Agouridas, V., Magnier, E., Blazejewski, J., Laı̈os, I., Cleeren, A., Nonclercq, D., Laurent, G., & Leclercq, G. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm801154q · Cited by 12
Riva, R., Banfi, L., Castaldi, G., Ghislieri, D., Malpezzi, L., Musumeci, F., Tufaro, R., & Rasparini, M. (2011) · European Journal of Organic Chemistry · doi:10.1002/ejoc.201001618 · Cited by 12
Hogan, P. J., Powell, L., & Robinson, G. E. (2010) · Organic Process Research & Development · doi:10.1021/op1001319 · Cited by 11
Diastereoselective Reduction of the Enone Intermediate of Travoprost
Aswathanarayanappa, C., Bheemappa, E., & Bodke, Y. D. (2011) · Organic Process Research & Development · doi:10.1021/op200154p · Cited by 9
Recent Progress in the Discovery of Kv7 Modulators
Dorange, I. B., & Swahn, B. (2011) · Annual reports in medicinal chemistry · doi:10.1016/b978-0-12-386009-5.00023-0 · Cited by 5
Review: Update on Newer Antihypertensive Medicines and Interventions
Wu, K. C., & Gerstenblith, G. (2010) · Journal of Cardiovascular Pharmacology and Therapeutics · doi:10.1177/1074248410368277 · Cited by 4
Crizotinib in ALK-positive lung cancer
Girard, N. (2012) · The Lancet Oncology · doi:10.1016/s1470-2045(12)70375-3 · Cited by 4
Research works printed but not linked: 301
- Christe K. O., 1986, Inorg. Chem., 25, 3721, 10.1021/ic00241a001 · doi:10.1021/ic00241a001
- Moissan H., 1896, C. R. Hebd. Acad. Sci., 128, 1543
- Ruff O., 1930, Z. Anorg. Allg. Chem., 190, 270, 10.1002/zaac.19301900127 · doi:10.1002/zaac.19301900127
- Baasner B., 2000, Houben-Weyl Methods of Organic Chemistry, 10
- Marais J. S. C., 1943, Onderstepoort J. Vet. Sci. Anim. Ind., 18, 203
- Marais J. S. C., 1944, Onderstepoort J. Vet. Sci. Anim. Ind., 20, 67
- Gribble G. W., 2004, J. Chem. Educ., 81, 1441, 10.1021/ed081p1441 · doi:10.1021/ed081p1441
- Fuchikami T., 1982, Tetrahedron Lett., 23, 4099, 10.1016/S0040-4039(00)88357-4 · doi:10.1016/s0040-4039(00)88357-4
- Ojima I., 1987, J. Am. Chem. Soc., 109, 7714, 10.1021/ja00259a020 · doi:10.1021/ja00259a020
- Ojima I., 1988, J. Am. Chem. Soc., 110, 150, 10.1021/ja00209a024 · doi:10.1021/ja00209a024
- Ojima I., 1989, J. Org. Chem., 54, 4511, 10.1021/jo00280a014 · doi:10.1021/jo00280a014
- Soloshonok V. A., 1994, Tetrahedron Lett., 35, 5063, 10.1016/S0040-4039(00)73320-X · doi:10.1016/s0040-4039(00)73320-x
- Katagiri T., 2001, Chem. Commun., 2054, 10.1039/b105602f · doi:10.1039/b105602f
- Fuchikami T., 1982, J. Am. Chem. Soc., 104, 3527, 10.1021/ja00376a057 · doi:10.1021/ja00376a057
- Fuchikami T., 1983, J. Org. Chem., 48, 3803, 10.1021/jo00169a040 · doi:10.1021/jo00169a040
- Ojima I., 1988, J. Am. Chem. Soc., 110, 5617, 10.1021/ja00225a004 · doi:10.1021/ja00225a004
- Soloshonok V. A., 1994, Tetrahedron Lett., 35, 2713, 10.1016/S0040-4039(00)77013-4 · doi:10.1016/s0040-4039(00)77013-4
- Soloshonok V. A., 1994, Tetrahedron: Asymmetry, 5, 1091, 10.1016/0957-4166(94)80059-6 · doi:10.1016/0957-4166(94)80059-6
- Kobzev S. V., 1989, Zh. Obshch. Khim., 59, 909
- Van Niel M. B., 1999, J. Med. Chem., 42, 2087, 10.1021/jm981133m · doi:10.1021/jm981133m
- Sparr C., 2009, Angew. Chem., Int. Ed., 48, 3065, 10.1002/anie.200900405 · doi:10.1002/anie.200900405
- Soloshonok V. A., 1996, Tetrahedron: Asymmetry, 7, 1547, 10.1016/0957-4166(96)00177-2 · doi:10.1016/0957-4166(96)00177-2
- Wakeling A. E., 1991, Cancer Res., 51, 3867
- Brazier E. J., 2010, Org. Process Res. Dev., 14, 544, 10.1021/op900315j · doi:10.1021/op900315j
- Ballard P., 2006, Bioorg. Med. Chem. Lett., 16, 4908, 10.1016/j.bmcl.2006.06.054 · doi:10.1016/j.bmcl.2006.06.054
- 1996, Chem. Abstr., 126, 47235
- 2004, Chem. Abstr., 140, 287403
- Chandregowda V., 2007, Org. Process Res. Dev., 11, 813, 10.1021/op700054p · doi:10.1021/op700054p
- Breitler S., 2011, Org. Lett., 13, 3262, 10.1021/ol201210t · doi:10.1021/ol201210t
- Rawling T., 2012, Tetrahedron, 68, 6065, 10.1016/j.tet.2012.05.002 · doi:10.1016/j.tet.2012.05.002
- Wagstaff A. J., 2003, Drugs, 63, 217, 10.2165/00003495-200363020-00009 · doi:10.2165/00003495-200363020-00009
- McGavin J. K., 2001, Drugs, 61, 2309, 10.2165/00003495-200161150-00015 · doi:10.2165/00003495-200161150-00015
- Koukourakis G. V., 2008, Molecules, 13, 1897, 10.3390/molecules13081897 · DOI
- Ishitsuka H., 1999, J. Pharm. Soc. Jpn., 119, 881, 10.1248/yakushi1947.119.12_881 · doi:10.1248/yakushi1947.119.12_881
- Shimma N., 2000, Bioorg. Med. Chem., 8, 1697, 10.1016/S0968-0896(00)00087-0 · doi:10.1016/s0968-0896(00)00087-0
- 1981, Chem. Abstr., 95, 62602
- Niedballa U., 1974, J. Org. Chem., 39, 3654, 10.1021/jo00939a008 · doi:10.1021/jo00939a008
- Saneyoshi M., 1978, Chem. Pharm. Bull., 26, 2990, 10.1248/cpb.26.2990 · doi:10.1248/cpb.26.2990
- Mendel D. B., 2003, Clin. Cancer Res., 9, 327
- Manley J. M., 2003, J. Org. Chem., 68, 6447, 10.1021/jo034304q · doi:10.1021/jo034304q
- Wang J.-Q., 2005, Bioorg. Med. Chem. Lett., 15, 4380, 10.1016/j.bmcl.2005.06.038 · doi:10.1016/j.bmcl.2005.06.038
- Davies J., 2011, Lancet Oncol., 12, 826, 10.1016/S1470-2045(11)70228-5 · doi:10.1016/s1470-2045(11)70228-5
- 2004, Chem. Abstr., 140, 77161
- Huang W.-S., 2007, Synthesis, 2121, 10.1055/s-2007-983754 · doi:10.1055/s-2007-983754
- Ueda S., 2012, J. Am. Chem. Soc., 134, 700, 10.1021/ja2102373 · doi:10.1021/ja2102373
- Basuli F., 2011, J. Labelled Compd. Radiopharm., 54, 633, 10.1002/jlcr.1898 · doi:10.1002/jlcr.1898
- Wood E. R., 2004, Cancer Res., 64, 6652, 10.1158/0008-5472.CAN-04-1168 · DOI · Paper page
- 2002, Chem. Abstr., 137, 119644
- Zhong W. Z., 2010, Curr. Drug Metab., 11, 296, 10.2174/138920010791514207 · doi:10.2174/138920010791514207
- Pennell N. A., 2012, Am. J. Manag. Care, 18, SP84
- 2006, Chem. Abstr., 144, 274297
- Ramachandran P. V., 2004, Tetrahedron Lett., 45, 2603, 10.1016/j.tetlet.2004.01.146 · doi:10.1016/j.tetlet.2004.01.146
- Xin B., 2012, Bioorg. Med. Chem. Lett., 22, 4783, 10.1016/j.bmcl.2012.05.053 · doi:10.1016/j.bmcl.2012.05.053
- Stellwagen J. C., 2011, Bioorg. Med. Chem. Lett., 21, 4436, 10.1016/j.bmcl.2011.06.021 · doi:10.1016/j.bmcl.2011.06.021
- Buck J. R., 2012, Tetrahedron Lett., 53, 4161, 10.1016/j.tetlet.2012.05.137 · doi:10.1016/j.tetlet.2012.05.137
- Baumann P., 2002, Eur. Neuropsychopharmacol., 12, 433, 10.1016/S0924-977X(02)00051-2 · DOI
- Zhang P., 2010, J. Med. Chem., 53, 6112, 10.1021/jm1005034 · doi:10.1021/jm1005034
- 1990, Chem. Abstr., 113, 78150
- 2009, Chem. Abstr., 150, 144285
- 2005, Chem. Abstr., 143, 26491
- 2006, Chem. Abstr., 144, 292567
- Elati C. R., 2007, Org. Process Res. Dev., 11, 289, 10.1021/op060175e · doi:10.1021/op060175e
- 2003, Chem. Abstr., 139, 73997
- Solares L. F., 2004, Tetrahedron: Asymmetry, 15, 341, 10.1016/j.tetasy.2003.10.022 · doi:10.1016/j.tetasy.2003.10.022
- 2006, Chem. Abstr., 146, 80528
- 2007, Chem. Abstr., 147, 211613
- Partridge B. M., 2011, Tetrahedron, 67, 10082, 10.1016/j.tet.2011.09.142 · doi:10.1016/j.tet.2011.09.142
- Muñoz M., 2012, Expert Opin. Ther. Pat., 22, 735, 10.1517/13543776.2012.697153 · doi:10.1517/13543776.2012.697153
- Lin P., 2007, Bioorg. Med. Chem. Lett., 17, 5191, 10.1016/j.bmcl.2007.06.085 · doi:10.1016/j.bmcl.2007.06.085
- Jiang J., 2009, J. Med. Chem., 52, 3039, 10.1021/jm8016514 · doi:10.1021/jm8016514
- Kolla N., 2007, Org. Process Res. Dev., 11, 455, 10.1021/op700030d · doi:10.1021/op700030d
- Vankawala P. J., 2007, Synth. Commun., 37, 3439, 10.1080/00397910701487473 · doi:10.1080/00397910701487473
- Pye P. J., 2002, Chem.—Eur. J., 8, 1372, 10.1002/1521-3765(20020315)8:6<1372::AID-CHEM1372>3.0.CO;2-6 · doi:10.1002/1521-3765(20020315)8:6<1372::aid-chem1372>3.0.co;2-6
- Zhao M. M., 2002, J. Org. Chem., 67, 6743, 10.1021/jo0203793 · doi:10.1021/jo0203793
- Cowden C. J., 2000, Tetrahedron Lett., 41, 8661, 10.1016/S0040-4039(00)01548-3 · doi:10.1016/s0040-4039(00)01548-3
- Payack J. F., 2004, Org. Process Res. Dev., 8, 256, 10.1021/op034180j · doi:10.1021/op034180j
- 2012, Chem. Abstr., 157, 663055
- 2009, Chem. Abstr., 151, 343563
- Elati C. R., 2007, Tetrahedron Lett., 48, 8001, 10.1016/j.tetlet.2007.09.051 · doi:10.1016/j.tetlet.2007.09.051
- Gangula S., 2010, Synth. Commun., 40, 2254, 10.1080/00397910903221084 · doi:10.1080/00397910903221084
- Brands K. M. J., 2006, Org. Process Res. Dev., 10, 109, 10.1021/op0501895 · doi:10.1021/op0501895
- Nelson T. D., 2004, Tetrahedron Lett., 45, 8917, 10.1016/j.tetlet.2004.09.185 · doi:10.1016/j.tetlet.2004.09.185
- Strupczewski J. T., 1995, J. Med. Chem., 38, 1119, 10.1021/jm00007a009 · doi:10.1021/jm00007a009
- Rado J., 2010, Expert Opin. Pharmacother., 11, 2087, 10.1517/14656566.2010.502889 · doi:10.1517/14656566.2010.502889
- 1993, Chem. Abstr., 118, 240939
- 2008, Chem. Abstr., 148, 308371
- 2011, Chem. Abstr., 155, 123430
- 2011, Chem. Abstr., 154, 158482
- 2011, Chem. Abstr., 155, 123425
- 2012, Chem. Abstr., 157, 548664
- Janardhana R. V., 2011, Pharm. Lett., 3, 240
- 2010, Chem. Abstr., 152, 144708
- Strupczewski J. T., 1985, J. Med. Chem., 28, 761, 10.1021/jm00383a012 · doi:10.1021/jm00383a012
- 1991, Chem. Abstr., 114, 185553
- 1995, Chem. Abstr., 123, 169657
- 1995, Chem. Abstr., 123, 314016
- 1998, Chem. Abstr., 129, 122674
- 2012, Chem. Abstr., 157, 708577
- 2010, Chem. Abstr., 152, 405725
- Patel D. S., 2011, Res. J. Pharm. Biol. Chem. Sci, 2, 855
- Hegde S., 2008, Annu. Rep. Med. Chem., 43, 455
- Wang J., 2006, Prog. Nat. Sci., 16, 925, 10.1080/10020070612330017 · DOI
- 1987, Chem. Abstr., 106, 156480
- 1999, Chem. Abstr., 130, 57245
- 2010, Chem. Abstr., 153, 382966
- 1998, Chem. Abstr., 128, 140707
- Arava V. R., 2011, Pharm. Chem., 3, 381
- 2012, Chem. Abstr., 156, 337316
- 2012, Chem. Abstr., 156, 390181
- Dorange I., 2011, Annu. Rep. Med. Chem., 46, 53
- 1993, Chem. Abstr., 119, 225705
- 2003, Chem. Abstr., 138, 137040
- 2012, Chem. Abstr., 157, 242074
- 1998, Chem. Abstr., 129, 104236
- Swahn C.-G., 1996, J. Labelled Compd. Radiopharm., 38, 675, 10.1002/(SICI)1099-1344(199607)38:7<675::AID-JLCR880>3.0.CO;2-L · doi:10.1002/(sici)1099-1344(199607)38:7<675::aid-jlcr880>3.0.co;2-l
- 2011, Chem. Abstr., 155, 94042
- Wu G., 1999, J. Org. Chem., 64, 3714, 10.1021/jo990428k · doi:10.1021/jo990428k
- Fu X., 2003, Tetrahedron Lett., 44, 801, 10.1016/S0040-4039(02)02700-4 · doi:10.1016/s0040-4039(02)02700-4
- Bertrand B., 2007, Tetrahedron Lett., 48, 2123, 10.1016/j.tetlet.2007.01.118 · doi:10.1016/j.tetlet.2007.01.118
- Kysliková E., 2010, J. Mol. Catal. B: Enzym., 67, 266, 10.1016/j.molcatb.2010.09.006 · doi:10.1016/j.molcatb.2010.09.006
- Sova M., 2010, Synthesis, 3433
- Michalak M., 2011, J. Org. Chem., 76, 6931, 10.1021/jo2010846 · doi:10.1021/jo2010846
- Wang X., 2012, Angew. Chem., Int. Ed., 51, 9276, 10.1002/anie.201204925 · doi:10.1002/anie.201204925
- aPfefferkorn, J. A.InThe art of drug synthesis;Johnson, D. S.; Li, J. J., Eds.John Wiley & Sons:Hoboken, NJ, 2007; pp169–182.
- Quirk J., 2003, Nat. Rev. Drug. Discovery, 2, 769, 10.1038/nrd1205 · doi:10.1038/nrd1205
- Konoike T., 1994, J. Org. Chem., 59, 7849, 10.1021/jo00104a049 · doi:10.1021/jo00104a049
- Korostylev A., 2008, Eur. J. Org. Chem., 840, 10.1002/ejoc.200701059 · doi:10.1002/ejoc.200701059
- Andrushko N., 2008, Eur. J. Org. Chem., 847, 10.1002/ejoc.200700813 · doi:10.1002/ejoc.200700813
- Časar Z., 2008, Synlett, 2036, 10.1055/s-2008-1077957 · doi:10.1055/s-2008-1077957
- Časar Z., 2009, Synlett, 1144, 10.1055/s-0028-1088152 · doi:10.1055/s-0028-1088152
- Hilas O., 2009, Pharm. Ther., 34, 188
- Siebert C. D., 2008, Chirality, 20, 103, 10.1002/chir.20509 · doi:10.1002/chir.20509
- Bai Y., 2006, J. Chem. Res., 807, 10.3184/030823406780199802 · doi:10.3184/030823406780199802
- Johannes C. W., 1998, J. Am. Chem. Soc., 120, 8340, 10.1021/ja981378o · doi:10.1021/ja981378o
- Visser M. S., 1996, J. Am. Chem. Soc., 118, 3779, 10.1021/ja960263m · doi:10.1021/ja960263m
- Harrity J. P. A., 1997, J. Am. Chem. Soc., 119, 1488, 10.1021/ja9636597 · doi:10.1021/ja9636597
- Encinas M. V., 1980, J. Am. Chem. Soc., 102, 1357, 10.1021/ja00524a021 · doi:10.1021/ja00524a021
- Trost B. M., 1988, Tetrahedron Lett., 29, 2931, 10.1016/0040-4039(88)85050-0 · doi:10.1016/0040-4039(88)85050-0
- Hoveyda A. H., 1993, Chem. Rev., 93, 1307, 10.1021/cr00020a002 · doi:10.1021/cr00020a002
- Chandrasekhar S., 2000, Tetrahedron, 56, 6339, 10.1016/S0040-4020(00)00572-X · doi:10.1016/s0040-4020(00)00572-x
- Wang N.-X., 2007, Synthesis, 1154, 10.1055/s-2007-965993 · doi:10.1055/s-2007-965993
- Carreño M. C., 2008, Eur. J. Org. Chem., 2035, 10.1002/ejoc.200800201 · doi:10.1002/ejoc.200800201
- Nakagawa S., 1995, Jpn. J. Pharm., 67, 1, 10.1254/jjp.67.1 · doi:10.1254/jjp.67.1
- Müller M., 2005, Angew. Chem., Int. Ed., 44, 362, 10.1002/anie.200460852 · doi:10.1002/anie.200460852
- Karanewsky D. S., 1991, J. Org. Chem., 56, 3744, 10.1021/jo00011a064 · doi:10.1021/jo00011a064
- Theisen P. D., 1988, J. Org. Chem., 53, 2374, 10.1021/jo00245a051 · doi:10.1021/jo00245a051
- Heathcock C. H., 1987, J. Med. Chem., 30, 1858, 10.1021/jm00393a030 · doi:10.1021/jm00393a030
- Rosen T., 1985, J. Am. Chem. Soc., 107, 3731, 10.1021/ja00298a062 · doi:10.1021/ja00298a062
- Rosen T., 1984, J. Org. Chem., 49, 3657, 10.1021/jo00193a044 · doi:10.1021/jo00193a044
- Fernandes R. A., 2002, Eur. J. Org. Chem., 2921, 10.1002/1099-0690(200209)2002:17<2921::AID-EJOC2921>3.0.CO;2-N · doi:10.1002/1099-0690(200209)2002:17<2921::aid-ejoc2921>3.0.co;2-n
- Ghosh A. K., 2002, J. Org. Chem., 67, 8783, 10.1021/jo020402k · doi:10.1021/jo020402k
- Rosen T., 1984, J. Org. Chem., 49, 3994, 10.1021/jo00195a023 · doi:10.1021/jo00195a023
- Kumar P., 2010, Tetrahedron Lett., 51, 5838, 10.1016/j.tetlet.2010.08.093 · doi:10.1016/j.tetlet.2010.08.093
- Reddy M. V. R., 2001, J. Organomet. Chem., 624, 239, 10.1016/S0022-328X(01)00665-9 · doi:10.1016/s0022-328x(01)00665-9
- Takahashi K., 1993, Tetrahedron Lett., 34, 8263, 10.1016/S0040-4039(00)61406-5 · doi:10.1016/s0040-4039(00)61406-5
- Lopp M., 1991, Tetrahedron: Asymmetry, 2, 943, 10.1016/S0957-4166(00)86131-5 · doi:10.1016/s0957-4166(00)86131-5
- Minami T., 1992, Tetrahedron Lett., 33, 7525, 10.1016/S0040-4039(00)60814-6 · doi:10.1016/s0040-4039(00)60814-6
- Reddy B., 1991, J. Org. Chem., 56, 5752, 10.1021/jo00020a008 · doi:10.1021/jo00020a008
- Takano S., 1993, Tetrahedron: Asymmetry, 4, 201, 10.1016/S0957-4166(00)82337-X · doi:10.1016/s0957-4166(00)82337-x
- Miyachi N., 1993, Tetrahedron Lett., 34, 8267, 10.1016/S0040-4039(00)61407-7 · doi:10.1016/s0040-4039(00)61407-7
- Suzuki M., 2001, Bioorg. Med. Chem., 9, 2727, 10.1016/S0968-0896(01)00198-5 · DOI
- Acemoglu M., 2007, Helv. Chim. Acta, 90, 1069, 10.1002/hlca.200790106 · doi:10.1002/hlca.200790106
- Fabris J., 2012, Synthesis, 1700
- Serebruany V., 2009, Thromb. Haemostasis, 101, 14, 10.1160/TH08-07-0452 · doi:10.1160/th08-07-0452
- Huber K., 2009, Nat. Rev. Drug Discovery, 8, 449, 10.1038/nrd2899 · doi:10.1038/nrd2899
- Hasegawa M., 2005, Thromb. Haemostasis, 94, 593, 10.1160/TH05-03-0208 · doi:10.1160/th05-03-0208
- Dobesh P. P., 2009, Pharmacotherapy, 29, 1393, 10.1592/phco.29.12.1393 · doi:10.1592/phco.29.12.1393
- 2009, Chem. Abstr., 151, 266755
- Aalla S., 2012, Org. Process Res. Dev., 16, 240, 10.1021/op200325u · doi:10.1021/op200325u
- Pan X., 2012, Tetrahedron Lett., 53, 5364, 10.1016/j.tetlet.2012.07.071 · doi:10.1016/j.tetlet.2012.07.071
- Zhang H., 2012, Bioorg. Med. Chem. Lett., 22, 3598, 10.1016/j.bmcl.2012.04.050 · doi:10.1016/j.bmcl.2012.04.050
- Groll A. H., 1998, Adv. Pharmacol. (San Diego, CA, U.S.), 44, 343
- Tasaka A., 1993, Chem. Pharm. Bull., 41, 1035, 10.1248/cpb.41.1035 · doi:10.1248/cpb.41.1035
- Richardson K., 1988, Ann. N.Y. Acad. Sci., 544, 6
- Tasaka A., 1995, Chem. Pharm. Bull., 43, 441, 10.1248/cpb.43.441 · doi:10.1248/cpb.43.441
- Butters M., 2001, Org. Process Res. Dev., 5, 28, 10.1021/op0000879 · doi:10.1021/op0000879
- 1997, Chem. Abstr., 127, 262316
- 1995, Chem. Abstr., 123, 339705
- Butters M., 1992, J. Heterocycl. Chem., 1369, 10.1002/jhet.5570290554 · doi:10.1002/jhet.5570290554
- Frampton J. E., 2005, Drugs, 65, 1427, 10.2165/00003495-200565100-00008 · doi:10.2165/00003495-200565100-00008
- Molina J. M., 2005, Drugs Today, 41, 241, 10.1358/dot.2005.41.4.900219 · doi:10.1358/dot.2005.41.4.900219
- Cahn P., 2004, Expert Opin. Invest. Drugs, 13, 55, 10.1517/13543784.13.1.55 · doi:10.1517/13543784.13.1.55
- Bang L. M., 2003, Drugs, 63, 2413, 10.2165/00003495-200363220-00003 · doi:10.2165/00003495-200363220-00003
- Gentile I., 2006, Curr. Med. Chem., 13, 2839, 10.2174/092986706778521995 · doi:10.2174/092986706778521995
- Nelson M., 2004, Int. J. Clin. Pract., 58, 504, 10.1111/j.1368-5031.2004.00100.x · doi:10.1111/j.1368-5031.2004.00100.x
- 1992, Chem. Abstr., 118, 22551
- 2000, Chem. Abstr., 132, 166456
- Hoong L. K., 1992, J. Org. Chem., 57, 5563, 10.1021/jo00047a004 · doi:10.1021/jo00047a004
- Osborne A. P., 2006, Org. Process Res. Dev., 10, 670, 10.1021/op050258f · doi:10.1021/op050258f
- Gaede B. J., 2005, Org. Process Res. Dev., 9, 23, 10.1021/op040210m · doi:10.1021/op040210m
- Agarwal H. K., 2012, J. Med. Chem., 55, 2672, 10.1021/jm201551m · doi:10.1021/jm201551m
- Agarwal H. K., 2013, Mol. Pharmaceutics, 10, 467, 10.1021/mp300361a · doi:10.1021/mp300361a
- Rusconi S., 2009, Expert Rev. Clin. Pharmacol., 2, 147, 10.1586/17512433.2.2.147 · doi:10.1586/17512433.2.2.147
- Orman J. S., 2008, Drugs, 68, 1435, 10.2165/00003495-200868100-00006 · doi:10.2165/00003495-200868100-00006
- Temesgen Z., 2005, Drugs Today, 41, 71, 10.1358/dot.2005.41.11.937960 · doi:10.1358/dot.2005.41.11.937960
- Wroblewski A., 1998, Drugs Future, 23, 146, 10.1358/dof.1998.023.02.445832 · doi:10.1358/dof.1998.023.02.445832
- Thaisrivongs S., 1996, J. Med. Chem., 39, 4349, 10.1021/jm960541s · doi:10.1021/jm960541s
- Turner S. R., 1998, J. Med. Chem., 41, 3467, 10.1021/jm9802158 · doi:10.1021/jm9802158
- Judge T. M., 1997, J. Am. Chem. Soc., 119, 3627, 10.1021/ja963434w · doi:10.1021/ja963434w
- Soloshonok V. A., 2002, Helv. Chim. Acta, 85, 3616, 10.1002/1522-2675(200211)85:11<3616::AID-HLCA3616>3.0.CO;2-O · doi:10.1002/1522-2675(200211)85:11<3616::aid-hlca3616>3.0.co;2-o
200 of 301 shown
Cited by
Photoredox Catalysis in Organic Chemistry
Shaw, M. H., Twilton, J., & MacMillan, D. W. C. (2016) · The Journal of Organic Chemistry · doi:10.1021/acs.joc.6b01449 · Cited by 3,186
Fluorine and Fluorinated Motifs in the Design and Application of Bioisosteres for Drug Design
Meanwell, N. A. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b01788 · Cited by 2,655
3d Transition Metals for C–H Activation
Gandeepan, P., Müller, T., Zell, D., Cera, G., Warratz, S., & Ackermann, L. (2019) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00507 · Cited by 2,332
Contribution of Organofluorine Compounds to Pharmaceuticals
Inoue, M., Sumii, Y., & Shibata, N. (2020) · ACS Omega · doi:10.1021/acsomega.0c00830 · Cited by 1,944
Current Contributions of Organofluorine Compounds to the Agrochemical Industry
Ogawa, Y., Tokunaga, E., Kobayashi, O., Hirai, K., & Shibata, N. (2020) · iScience · doi:10.1016/j.isci.2020.101467 · Cited by 1,253
Metadata
- Authors
- Wang, J., Sánchez-Roselló, M., Aceña, J. L., del Pozo, C., Sorochinsky, A. E., Fustero, S., Soloshonok, V. A., & Liu, H.
- Venue
- Chemical Reviews
- Publisher
- American Chemical Society (ACS)
- Published
- 2013-12-03
- Volume
- 114
- Issue
- 4
- Pages
- 2432-2506
- ISSN
- 0009-2665 (ISSN-L)
- 1520-6890
- OpenAlex
- W2333129245
- Cited by
- 4,847
- References
- 254
- FWCI
- 75.99
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.